María Rosado Sanz

Ms. María Rosado Sanz

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
MSMaría Rosado Sanz
María Rosado Sanz
NANuria Martinez Alarcon
Nuria Martinez Alarcon
ASAdrián Abellán Soriano
Adrián Abellán Soriano
RMRaúl Golfe San Martín
Raúl Golfe San Martín
ETEva M Trinidad
Eva M Trinidad
JMJaime Font de Mora
Jaime Font de Mora
Triple-negative breast cancer (TNBC) remains a challenging subtype of breast cancer due to its aggressive nature and lack of targeted therapies. Cytokines play a pivotal role in shaping the tumor microenvironment, modulating tumor progression, immune evasion, and therapy resistance. In this review, we discuss the complex cytokine networks involved in TNBC biology, highlighting their contribution to key oncogenic processes, including proliferation, angiogenesis, epithelial–mesenchymal transition, and immunomodulation. We also summarize current and emerging cytokine-targeted therapeutic strategies, including monoclonal antibodies, bispecific antibodies, cell-based therapies, and cytokine-armed CAR-T and CAR-NK cell approaches, with a focus on clinical implications and future directions.

19 June 2026 in OncoImmunology
Verified
Journal Article
Open access
MSMaría Rosado Sanz
María Rosado Sanz
NANuria Martinez Alarcon
Nuria Martinez Alarcon
MMMichaël H. Meel
Michaël H. Meel
SRSergio Rius-Pérez
Sergio Rius-Pérez
ZTZoey J. Tolboom
Zoey J. Tolboom
JMJaime Font de Mora
Jaime Font de Mora
Triple-negative breast cancer (TNBC) is characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and HER2 expression on tumor cells. Compared to other breast cancer subty...

28 July 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
RBRebeca Burgos-Panadero
Rebeca Burgos-Panadero
MSMaría Rosado Sanz
María Rosado Sanz
VMVictor Montosa-I-Mico
Victor Montosa-I-Mico
ZTZoey J Tolboom
Zoey J Tolboom
NANuria Martinez Alarcon
Nuria Martinez Alarcon
JMJaime Font de Mora
Jaime Font de Mora
Background: Glioblastoma (GBM) is a highly heterogeneous and vascularized malignancy in which the mesenchymal (MES) subtype is associated with poor prognosis, extensive macrophage infiltration and resistance to therapy. However, the signaling mechanisms integrating vascular remodeling with inflammatory tumor-macrophage crosstalk remain incompletely understood. Methods: We integrated magnetic resonance imaging-derived vascular phenotyping with transcriptomic analyses of human glioblastoma cohorts to identify molecular pathways associated with highly vascular tumors. Functional studies using glioblastoma cell lines, THP-1-derived macrophages and co-culture systems were performed to investigate the role of PI3K signaling in tumor-macrophage communication. Finally, an independent single-cell transcriptomic cohort of primary human glioblastoma was interrogated to determine whether the identified inflammatory programs were conserved in malignant cells from patient tumors. Results: Integrated imaging-transcriptomic analyses identified highly vascular glioblastomas as tumors enriched for the MES subtype, increased macrophage infiltration and activation of PI3K-associated signaling. Pharmacological inhibition of PI3K reduced the expression of macrophage-recruiting cytokines and impaired the ability of glioblastoma cells to educate macrophages toward an immunosuppressive phenotype. Reciprocally, tumor-educated macrophages enhanced inflammatory signaling, immune checkpoint expression and migratory capacity in glioblastoma cells, whereas IL-6 blockade attenuated these effects, identifying IL-6 as a key mediator of this bidirectional communication. To determine whether these inflammatory programs were conserved in human disease, we analyzed an independent single-cell transcriptomic dataset of primary glioblastomas. MES-like malignant cells exhibited the strongest inflammatory transcriptional programs among the four malignant transcriptional states, including higher NF-κB activation program scores and tumor-macrophage communication signature scores. At the tumor level, MES-like enrichment was positively associated with higher inflammatory program activity, supporting the clinical relevance of the proposed signaling axis. Conclusions: Together, our findings identify PI3K signaling as a central regulator integrating vascular remodeling with inflammatory tumor-macrophage communication in mesenchymal glioblastoma. These results provide a mechanistic framework linking PI3K signaling, macrophage education and the MES phenotype, and provide a rationale for therapeutic strategies aimed at disrupting inflammatory signaling within the glioblastoma microenvironment.